Tiny lab-grown brain models and the particles they release may reveal hidden differences among Alzheimer’s patients. Personalized treatment remains one of the biggest challenges in Alzheimer’s disease. Two patients can receive the same medication for symptoms such as depression, anxiety, or agitation and experience very different outcomes, leaving doctors with few ways to predict who [...]

New ACC/AHA cholesterol guidelines promote earlier detection, personalized risk assessment, and more aggressive LDL cholesterol lowering to reduce long-term cardiovascular disease risk. For decades, cholesterol management has been a cornerstone of heart disease prevention. Yet despite widespread awareness, cardiovascular disease remains the leading cause of death worldwide, and millions of adults continue to have cholesterol [...]